Self-administered rehabilitation for motion sickness and vestibular disorders

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a self-administered rehabilitation tool designed to help individuals with vestibular disorders, including vestibular schwannoma and motion sickness. Participants will perform guided head rotations in a structured manner, adjusting the amplitude based on their perception of motion sickness. The device tracks eye and head movements to assess the effectiveness of the rehabilitation. The goal is to enhance postural recovery and reduce symptoms of motion sickness through incremental training.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Provision of signed and dated informed consent form
2. Stated willingness to comply with all study procedures and availability for the duration of the study
3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma
4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen

Exclusion Criteria:

1. Current use of anti-nausea medication
2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis)
3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery)
4. Legal blindness (20/200 or worse visual acuity)
5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days

Where it's running

• Johns Hopkins University
  Baltimore, Maryland, United States Recruiting
• Naval Medical Research Unit
  Dayton, Ohio, United States Enrolling by invitation

Study contacts

• Principal investigator: Matthew Stewart, MD PhD — Johns Hopkins University
• Study coordinator: Michael Schubert, PhD
• Email: mschube1@jhmi.edu
• Phone: 4108427403

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• 3D MRI Elastography to Peek at Vestibular Schwannoma Stiffness and How It Relates to Surgery

  This study tests whether 3D MRI elastography can noninvasively measure how stiff vestibular schwannomas are and how firmly they stick to nearby tissues, to help predict surgical difficulty and outcomes.

  Recruiting Shengjing Hospital · Shenyang, Liaoning · NCT07844460

• HEADS Registry: Headache, Ear, Auditory, Dizziness, and Sinus</n> Registry

  This registry tests whether collecting online symptom reports from adults in the U.S. with sinus, vestibular, ear, or headache symptoms can help improve diagnosis and treatment.

  Recruiting Association of Migraine Disorders · North Kingstown, Rhode Island · NCT07754266

• Vestibular rehabilitation for adults having surgery for a unilateral vestibular schwannoma

  This trial tests whether home-based vestibular telerehabilitation before and after surgery, and adding preoperative rotatory chair sessions, can help adults recover balance and reduce dizziness after removal of a unilateral vestibular schwannoma.

  Recruiting Universitat Autonoma de Barcelona · Badalona, Barcelona · NCT07364955

• Nystagmus testing with wearable AR glasses in vertigo patients

  This study tests whether wearing AR glasses can match the standard eye-movement exam for classifying central vs peripheral vertigo in adults with dizziness.

  Recruiting Chang Gung Memorial Hospital · Kaohsiung, Taiwan · NCT07238387

• Testing brain vestibular centers after vestibular schwannoma surgery with MRI

  We’re testing whether brain areas that control balance light up differently in people after vestibular schwannoma surgery compared to healthy individuals using MRI.

  Recruiting Charles University, Czech Republic · Prague · NCT07130851

• Steroids to protect facial nerve function after skull-base surgery for vestibular schwannoma

  This trial tests whether giving steroids after vestibular schwannoma surgery helps preserve facial nerve function compared with a placebo.

  Recruiting Phase 3 Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT07116811

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.